Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins – Commercial and Individual Exchange Medical Policyopen_in_new

UnitedHealthcare covers reconstructive treatment of GSV, SSV and accessory saphenous veins with thermal ablation (RFA, EVLA), stripping/ligation/excision, endovenous foam sclerotherapy, and cyanoacrylate adhesive — and RFA/EVLA ablation of incompetent perforator veins — when criteria are met, while labeling MOCA, VenoValve, foam or cyanoacrylate for perforator veins, most stand‑alone ligations (except saphenofemoral ligation to prevent clot propagation when anticoagulation fails), and cosmetic treatments (spider veins/telangiectasias, endovenous ablation of reticular/telangiectatic veins, and >3 sclerotherapy sessions per leg/12 months) as unproven or excluded. Coverage requires standing or reverse‑Trendelenburg duplex ultrasound documentation showing vein diameter thresholds (GSV/SSV/accessory ≥3.0 mm; perforators ≥3.5 mm where applicable), reflux ≥500 ms, presence of a qualifying clinical impairment (skin ulceration, bleeding, superficial thrombophlebitis, venous stasis dermatitis, or moderate–severe pain), and supporting medical records, and remains subject to member‑specific benefit terms.